* Deloitte Access Economics. Reawakening Australia: the economic cost of sleep disorders in Australia, 2010. Canberra, Australia.
** Lavery D, Hart C et al. Safety and Efficacy of a Novel Oral Appliance in the Treatment of Obstructive Sleep Apnea. Journal of Dental Sleep Medicine Vol.4 No.3 July 2017
Welcome to the unique alternative for snorers and sufferers of mild-to-moderate obstructive sleep apnoea (OSA). The Oventus Treatment Platform may also offer a suitable alternative to those who cannot tolerate Continuous Positive Airway Pressure (CPAP). OSA is a serious condition, so speak to your healthcare professional for a diagnosis and to discuss if an oral device could help you.
An Oventus clinical trial showed that 100% of patients experienced a significant reduction in snoring with 82% eliminating snoring completely and 76% reducing their Apnoea Hypopnea Index (AHI) by more than half.**
Now is the time to explore the possibility that this treatment could really work for you.